This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1pzi

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1pzi.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1pzi.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1pzi| PDB=1pzi | SCENE= }}
{{STRUCTURE_1pzi| PDB=1pzi | SCENE= }}
-
'''Heat-Labile Enterotoxin B-Pentamer Complexed With Nitrophenyl Galactoside 2a'''
+
===Heat-Labile Enterotoxin B-Pentamer Complexed With Nitrophenyl Galactoside 2a===
-
==Overview==
+
<!--
-
With the aim of developing high-affinity mono and multivalent antagonists of cholera toxin (CT) and Escherichia coli heat-labile enterotoxin (LT) we are using the galactose portion of the natural receptor ganglioside GM1 as an anchoring fragment in structure-based inhibitor design efforts. In order to establish a better structure-activity relationship for guiding these studies, we designed and prepared a small focused library of twenty 3,5-substituted phenylgalactosides based on two previous leads. The compounds were tested for their ability to block CTB(5) binding to immobilized ganglioside receptor and compared to the two previous leads. The crystal structures of the most promising compounds bound to either CTB(5) or LTB(5) were then determined in order to understand the basis for affinity differences. The most potent new compound yielded a six-fold improvement over our benchmark lead m-nitrophenyl-alpha-d-galactopyranoside (MNPG), and a two-fold improvement in IC(50) over a newer MNPG derivative. These results support the notion that the m-nitrophenyl moiety of MNPG and its derivatives is an important element to retain in future optimization efforts. Additionally, a consensus binding-pocket for the alkylmorpholine or piperazine moiety present in all of the designed antagonists was established as an important area of the GM1 binding site to target in future work.
+
The line below this paragraph, {{ABSTRACT_PUBMED_14980603}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 14980603 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_14980603}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Pentamer]]
[[Category: Pentamer]]
[[Category: Toxin]]
[[Category: Toxin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 05:40:55 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 08:58:58 2008''

Revision as of 05:59, 28 July 2008

Image:1pzi.png

Template:STRUCTURE 1pzi

Heat-Labile Enterotoxin B-Pentamer Complexed With Nitrophenyl Galactoside 2a

Template:ABSTRACT PUBMED 14980603

About this Structure

1PZI is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.

Reference

3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies., Mitchell DD, Pickens JC, Korotkov K, Fan E, Hol WG, Bioorg Med Chem. 2004 Mar 1;12(5):907-20. PMID:14980603

Page seeded by OCA on Mon Jul 28 08:58:58 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1pzi"
Personal tools